Psych MEQs / SAQs · Consultation-liaison psychiatry
Demoralisation vs adjustment vs MDD in medical illness (MEQ)
FRANZCP-style MEQ on demoralisation vs adjustment vs MDD, DS/DS-II, DHD, dignity/MCP/CALM, Rayner antidepressant logic, and C-L disposition.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation and discriminators. Since the bad-news clinic (identifiable medical stressor within months), impairing distress without full MDD supports adjustment disorder if DSM-5-TR timing/significance/exclusion rules are met.[8] Concurrent demoralisation is suggested by pointlessness, trapped feeling, and subjective inability to cope with retained reactivity to her daughter — Clarke/Kissane phenomenology and Kissane demoralisation syndrome framing.[1][2] Major depression is less likely currently: no pervasive anhedonia or marked worthlessness; PHQ-9 is moderate and contaminated by medical sleep/symptom items — but reassess because demoralisation and MDD can coexist and trajectories evolve.[1] Passive wish that death come sooner is desire for hastened death (DHD) spectrum content, not a standalone diagnosis.[4]
(ii) Assessment. Structure: illness narrative and goals of care; physical symptom burden (orthopnoea-driven insomnia); MSE (reactivity, anhedonia, hopelessness, cognition); full suicide/DHD enquiry (plan/intent/means); capacity if major treatment decisions loom; collateral from daughter and cardiology/palliative team. Measurement options: Demoralisation Scale / DS-II for demoralisation severity; PHQ-9 for depression tracking with somatic caution; distress tools as available.[3][4]
(iii) Management. Optimise heart-failure symptoms and sleep hygiene with the medical team first — orthopnoea is not primarily a benzodiazepine problem. Psychological core: problem-solving for controllable domains; meaning/dignity-oriented work — name dignity therapy, meaning-centred psychotherapy, or CALM-style advanced-illness therapy as energy allows; hope-focused brief work.[5][6] Do not start an antidepressant solely for pure demoralisation/adjustment without MDD. If full MDD develops and prognosis allows a trial, start carefully, e.g. sertraline 25–50 mg oral daily titrating toward response, or mirtazapine 7.5–15 mg oral at night if sleep/appetite are priorities — monitor hyponatraemia, sedation, interactions, early suicide risk; reassess 1–2 weeks.[7] Safety plan for DHD content; avoid chronic benzodiazepine default.[4][8]
(iv) Liaison and disposition. Joint cardiology–palliative–psychiatry plan; family education; spiritual care if wanted; follow-up intensity scaled to risk; clear documentation so "adjustment" is not a soft exit without review. Escalate if suicidal intensity rises or MDD criteria emerge.[1][4][8]
References
- [1]Clarke DM, Kissane DW Demoralization: its phenomenology and importance Aust N Z J Psychiatry, 2002.PMID 12406115
- [2]Kissane DW, Clarke DM, Street AF Demoralization syndrome--a relevant psychiatric diagnosis for palliative care J Palliat Care, 2001.PMID 11324179
- [3]Kissane DW, Wein S, Love A, et al. The Demoralization Scale: a report of its development and preliminary validation J Palliat Care, 2004.PMID 15690829
- [4]Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer JAMA, 2000.PMID 11147988
- [5]Chochinov HM, Kristjanson LJ, Breitbart W, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial Lancet Oncol, 2011.PMID 21741309
- [6]Rodin G, Lo C, Rydall A, et al. Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients With Advanced Cancer J Clin Oncol, 2018.PMID 29958037
- [7]Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis Palliat Med, 2011.PMID 20935027
- [8]Bachem R, Casey P Adjustment disorder: A diagnosis whose time has come J Affect Disord, 2018.PMID 29107817